Key facts
- This page summarizes Jonathan Peri's Form 3 filing for CITIUS ONCOLOGY, INC. (CTOR).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 14 Aug 2026, 17:57.
Jonathan Peri - 10 Aug 2026 Form 3 Insider Report for CITIUS ONCOLOGY, INC. (CTOR)
- Reporting relationship
- Director
- Issuer ticker
- CTOR
- Reported as of
- 10 Aug 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Alexander M. Donaldson, by Power of Attorney
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Jonathan Peri filed Form 3 for CITIUS ONCOLOGY, INC. (CTOR) on 14 Aug 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002149660
Primary reporting owner
Peri Jonathan
- Relationship
- Director
- Address
- C/O CITIUS ONCOLOGY, INC., 11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD
- Signature
- /s/ Alexander M. Donaldson, by Power of Attorney
- Signature date
- 14 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CTOR
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 0
- Date
- 10 Aug 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.